In The News

Stay updated on the rapidly evolving field of pharmacogenetics

Every day new research is conducted and additional guidelines are published on how to integrate this science into clinical practice.

Financial Analysis of CYP2C19 Genotyping in Patients Receiving Dual Antiplatelet Therapy Following Acute Coronary Syndrome and Percutaneous Coronary Intervention

A budget analysis found significant savings for patients who undergo CYP2C19 pharmacogenetic testing. Published July, 2015

With Diagnostic Tests, It’s a Brave New World

AARP lists pharmacogenetics as one of six game-changing medical tests backed by real science. Published May, 2015

New Albany company expanding with genetic test to help choose best meds

Columbus Business First highlights Chromocare’s July 1st launch of The G.A.P Test. Published April 2, 2015

Obama seeks $215 million for precision medicine

$215 Million dedicated to personalized medicine (including pharmacogenomics) in President Obama’s proposed budget, which he announced in the State of the Union Address. Published January 30, 2015

Guidelines for the primary prevention of stroke: A statement for healthcare professionals from the American Heart Association/American Stroke Association

PGx tests moved from Class III (not recommended) to Class IIb (may be considered) for Vitamin K antagonists (warfarin) when therapy is initiated. Published October 28, 2014

New APA Award Recognizes Emerging Field of Pharmacogenomics

Lecture established at APA annual conference to honor pioneers in pharmacogenomics. Published October 22, 2014

Could genetic testing help doctors treat pain more effectively?

Dr. Anita Gupta, an Award Winning Johns Hopkins Trained Anesthesiologist, Pain Specialist, Pharmacist & Editor speaks with Fox News about the benefits of Pharmacogenetic testing. Published August 6, 2013